Global Throat Lozenges Market Valuation and Growth Prospects: $9.45 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the throat lozenges market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Throat Lozenges Market Size?

The liraglutide market has shown substantial growth in recent years. It is anticipated to expand from $6.38 billion in 2024 to $6.88 billion in 2025, progressing at a compound annual growth rate (CAGR) of 7.9%. This past expansion can be ascribed to several factors, including the rising number of individuals diagnosed with type 2 diabetes, increasing rates of obesity, extensive clinical trials, heightened awareness concerning diabetes complications, and advancements in drug delivery systems.

The liraglutide market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $9.45 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.3%. This expansion during the projection period stems from factors such as the rise in insurance and reimbursement frameworks, advancements in healthcare infrastructure, heightened awareness and educational efforts, an expanding elderly demographic, and the increasing incidence of diabetes. Key developments anticipated in this period encompass the application of artificial intelligence and machine learning, a rising need for wearable technologies, the incorporation of continuous glucose monitoring, breakthroughs in biotechnology, and the creation of digital health platforms.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18659&type=smp

What Core Market Drivers Are Expanding The Throat Lozenges Industry?

The expanding number of individuals with diabetes is anticipated to boost the growth of the liraglutide market in the future. Diabetes is a long-term illness characterized by the body’s inability to adequately control blood sugar levels, stemming from either inadequate insulin production or inefficient utilization of insulin. The occurrence of diabetes is on the rise, influenced by factors like inactive lifestyles, poor dietary habits, and increasing global obesity levels. Medications for diabetes, including liraglutide, function by imitating the effects of the GLP-1 hormone, thereby improving insulin secretion, reducing blood glucose, and encouraging weight loss, which assists in managing type 2 diabetes. For example, in March 2024, a report from the Government of the United Kingdom, a UK-based information source, indicated that in March 2023, the percentage of individuals with type 1 diabetes in England who received all eight recommended care processes at GP practices participating in the NDA rose to 43.8%, up from 35.2% in the previous year. Consequently, the growing population affected by diabetes is fueling the expansion of the liraglutide market.

What Segment Insights Are Highlighted In The Throat Lozenges Market Report?

The liraglutide market covered in this report is segmented –

1) By Brands: Victoza, Saxenda

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Drug Stores, Online Pharmacies

3) By Type Of Application: Diabetes Treatment, Weight Management

4) By End-Users: Hospitals And Clinics, Homecare Settings

Subsegments:

1) By Victoza: Type 2 Diabetes Treatment Or Weight Management

2) By Saxenda: Weight Loss Treatment Or Obesity Management

Which Notable Trends Are Transforming The Throat Lozenges Market Outlook?

Leading companies in the liraglutide market are actively developing new products, such as generic GLP-1, aiming to expand treatment options and fulfill the market’s need for more cost-effective alternatives. Generic GLP-1 refers to versions of GLP-1 receptor agonists manufactured after the patent protection on the original branded medications has expired, providing economical choices for managing conditions like type 2 diabetes and obesity. For instance, in June 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, introduced the first generic GLP-1, similar to Victoza, in the U.S. market, thereby addressing the growing demand for these therapies. Liraglutide injections are prescribed to enhance blood sugar management in adults and children aged 10 and above with type 2 diabetes and to reduce the risk of cardiovascular incidents in adults who have type 2 diabetes and existing cardiovascular conditions.

Which Firms Are Driving Innovation Within The Throat Lozenges Market?

Major companies operating in the liraglutide market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Biocon Limited, Hanmi Pharmaceutical Co. Ltd., Intarcia Therapeutics Inc., Adocia SA

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

What Regional Trends Are Shaping Growth In The Throat Lozenges Market?

North America was the largest region in the liraglutide market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the liraglutide market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18659&type=smp

Browse Through More Reports Similar to the Global Throat Lozenges Market 2025, By The Business Research Company

Antidiarrheals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antidiarrheals-global-market-report

Anti Aging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anti-aging-global-market-report

Anticoagulant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795